Trium Capital’s HilleVax HLVX Stock Holding History

Trium Capital’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-395,188	Closed	-$786K	–	64
2025 Q2	$786K	Buy	395,188 +16,983	+4%	+$31.1K	0.2%	36
2025 Q1	$548K	Buy	+378,205	New	+$699K	0.07%	40
2024 Q4	–	Sell	-453,260	Closed	-$798K	–	51
2024 Q3	$798K	Buy	+453,260	New	+$1.16M	0.23%	46

Trium Capital's HLVX Position: Q3 2025 in Review

Trium Capital sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 395,188 shares — an estimated $786K sold.

Trium Capital first reported a position in HLVX in Q3 2024 and held it in 3 quarters. The position peaked at $798K in Q3 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

Trium Capital reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
Trium Capital sold 395,188 HilleVax shares in Q3 2025, an estimated $786K.
Trium Capital first reported a position in HilleVax in Q3 2024 and held it in 3 quarters.
Trium Capital's HilleVax position peaked at $798K in Q3 2024.
1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Trium Capital's 13F filing for Q3 2025, filed 16 Oct 2025.